These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16454207)

  • 1. Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
    Aguirre G; Boiani M; Cerecetto H; Fernández M; González M; León E; Pintos C; Raymondo S; Arredondo C; Pacheco JP; Basombrío MA
    Pharmazie; 2006 Jan; 61(1):54-9. PubMed ID: 16454207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives.
    De Souza AO; Pedrosa MT; Alderete JB; Cruz AF; Prado MA; Alves RB; Silva CL
    Pharmazie; 2005 May; 60(5):396-7. PubMed ID: 15918593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.
    Kemnitzer W; Kuemmerle J; Zhang HZ; Kasibhatla S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4410-5. PubMed ID: 19500976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
    Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
    Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides.
    Abu-Zaied MA; El-Telbani EM; Elgemeie GH; Nawwar GA
    Eur J Med Chem; 2011 Jan; 46(1):229-35. PubMed ID: 21115211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
    Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
    Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
    Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
    Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
    Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
    Cincotta L; Foley JW; MacEachern T; Lampros E; Cincotta AH
    Cancer Res; 1994 Mar; 54(5):1249-58. PubMed ID: 8118813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives.
    Huang Y; Liu M; Meng L; Feng P; Guo Y; Ying M; Zhu X; Chen Y
    Steroids; 2015 Sep; 101():7-14. PubMed ID: 26004429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro NO-releasing activities of ocotillol-type furoxans.
    Bi Y; Yang J; Ma C; Liu ZY; Zhang TT; Zhang XC; Lu J; Meng QG
    Pharmazie; 2015 Apr; 70(4):213-8. PubMed ID: 26012249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
    Kumar D; Sundaree S; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
    Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
    Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
    Du K; Cao X; Zhang P; Zheng H
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
    Fruttero R; Crosetti M; Chegaev K; Guglielmo S; Gasco A; Berardi F; Niso M; Perrone R; Panaro MA; Colabufo NA
    J Med Chem; 2010 Aug; 53(15):5467-75. PubMed ID: 20684594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
    Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
    Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxic evaluation of combretafurazans.
    Tron GC; Pagliai F; Del Grosso E; Genazzani AA; Sorba G
    J Med Chem; 2005 May; 48(9):3260-8. PubMed ID: 15857132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV.
    Boiani M; Cerecetto H; González M; Risso M; Olea-Azar C; Piro OE; Castellano EE; López de Ceráin A; Ezpeleta O; Monge-Vega A
    Eur J Med Chem; 2001 Oct; 36(10):771-82. PubMed ID: 11738485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.